Complement receptors (CRs) CD21 and CD35 form a coreceptor with CD19 and CD81 on murine B cells that when coligated with the B-cell receptor lowers the threshold of activation by several orders of magnitude. This intrinsic signaling role is thought to explain the impaired humoral immunity of mice bearing deficiency in CRs. However, CRs have additional roles on B cells independent of CD19, such as transport of C3-coated immune complexes and regulation of C4 and C3 convertase. To test whether association of CR with CD19 is necessary for their intrinsic activation-enhancing role, knockin mice expressing mutant receptors, Cr2 ⌬/⌬gfp , that bind C3 ligands but do not signal through CD19 were constructed. We found that uncoupling of CR and CD19 significantly diminishes survival of germinal center B cells and secondary antibody titers. However, B memory is less impaired relative to mice bearing a complete deficiency in CRs on B cells. These findings confirm the importance of interaction of CR and CD19 for coreceptor activity in humoral immunity but identify a role for CR in B-cell memory independent of CD19.
B
cells, like T cells, are regulated in large part by signals from the innate immune system (1-3). For example, engagement of complement (C3d)-coated antigen (Ag) by mature cognate B cells ligates the coreceptor (i.e., CD19, CD21, and CD81) and the B-cell receptor (BCR), enhancing BCR signaling by several orders of magnitude (1, 4) .
In mice, complement receptors CD21 and CD35 (CRs) are encoded at the Cr2 locus by splicing of message, and they are coexpressed primarily on B cells and follicular dendritic cells (FDCs) (5, 6 ). CD35 and CD21 bind similar split products of C3, but in addition CD35 binds C3b and C4b. CD35 also interacts with CD19 to form a B-cell coreceptor (7) . Systemic blocking of CR by antibody (8) (9) (10) or soluble receptor (11) results in impaired humoral immunity. Likewise, mice deficient in the receptors (Cr2 Ϫ/Ϫ ) bear impaired B-cell immunity to T-independent (12) (13) (14) and T-dependent Ags (15) (16) (17) , infectious bacteria (18) , and viruses (19, 20) . Studies using chimeric mice expressing CRs on either B cells (16) or FDCs (21, 22) indicate that overall humoral immunity is dependent on the presence of the receptors on both cell types. Thus, intrinsic B-cell signaling by the coreceptor and retention of Ags on FDCs are both important in B-cell immunity.
Recent studies demonstrate that CR expression on B cells is important in the transport of immune complexes (ICs). Bloodborne complexes of complement-coated Ags are bound rapidly by marginal zone (MZ) B cells and are transported into the splenic follicles (12, 13, 23) , and Ag is offloaded to FDCs (24) . An analogous role for CRs on follicular B cells in peripheral lymph nodes (LNs) was identified. ICs draining via afferent lymph are trapped by subcapsular sinus (SCS) macrophages and ''transferred'' to noncognate B cells in the underlying follicular region in a CR-dependent manner (25, 26) . The complement-coated ICs are then transported to FDCs in a manner similar to that proposed for MZ B cells. Thus, CRs have at least two intrinsic roles on B cells: coreceptor on cognate B cells, and transport of ICs by noncognate B cells. A third, less studied role for CRs on B cells is complement regulatory activity. All mammalian cells express complement regulatory proteins (CRPs), such as Decay Activating Factor (DAF) and membrane cofactor protein (MCP), which act to protect the host from complement activation on the cell surface (27) . In the mouse, DAF and Crry are the major CRPs expressed on host nucleated cells (28) (29) (30) ; however, CD35 also has complement regulatory activity. Thus, its deficiency could contribute to a loss of CRP activity that leads to activation of complement and an alteration in the local environment (31) .
To determine the functional importance of the interaction between CR and CD19, a gene-targeting approach was used to generate the mutant mouse line Cr2 ⌬/⌬gfp , where the transmembrane (Tm) and cytoplasmic tail (CyT) of HLA class I ␣ chain were substituted for the analogous region of CR. Based on studies in a B-cell line expressing a similar CR-HLA chimeric receptor, it was predicted that mutant B cells would lack functional coreceptor signaling but retain the ability to bind and transport C3d-coated ICs and maintain CRP activity (32 ⌬/⌬gfp chimeric mice. These findings confirm the importance of interaction of CR and CD19 for coreceptor activity in humoral immunity but identify additional roles for CRs in maintenance of B-cell memory.
prepared from both the mutant and deficient mice relative to WT (Fig. S1D) . Thus, in the absence of interaction between CD21/ CD35 and CD19, the levels of CD19 were increased, as found in Cr2 Ϫ/Ϫ mice.
Signaling via Mutant CR. Coligation of CD21 and CD19 with subthreshold BCR stimulus augments B-cell activation (16, 34, 35 (36) . Splenocytes were treated with an optimal amount of anti-IgM or a subthreshold level of duck egg lysozyme (DEL) alone or combined with C3d (rDEL-C3d 3 ). MD4 B cells from each mouse strain mobilized intracellular Ca 2ϩ in response to cross-linking with 10 g/mL anti-IgM (Fig. 1A Top) . As reported previously (34) , stimulation of MD4 B cells with DEL in amounts exceeding 100 nmol was sufficient to induce release of intracellular Ca 2ϩ independently of coreceptor ( Fig. 1 A Middle) . However, response to 1 nmol of DEL required both coreceptor and BCR signaling, as evidenced by lack of threshold response by WT MD4 B cells ( Fig. 1 A Middle) . MD4 B cells from all three lines were treated with 1 nmol of rDEL-C3d 3 and, as expected, WT MD4 B cells but not Cr2 Ϫ/Ϫ B cells were responsive. Notably, the mutant B cells were also unresponsive to 1 nmol of rDEL-C3d 3 , demonstrating that the coreceptor was not intact in the Cr2 ⌬/⌬gfp mice ( Fig. 1 A Bottom) .
As a further test, functional coreceptor activity was also evaluated in vitro by using a carboxyfluorescein succinimidyl ester (CFSE) proliferation assay. Splenocytes from the three lines of mice were labeled with CFSE before culture with CD40 antibody and optimal anti-IgM (Fig. 1B) . To test coreceptor signaling, mixed tetramers, composed of a suboptimal level of anti-IgM and C3d, and anti-CD40 were cultured with B cells for 3 days (Fig. 1B) (37) . WT B cells proliferated in response to mixed tetramers and anti-CD40, as demonstrated previously (37) , whereas Cr2 Ϫ/Ϫ and Cr2 ⌬/⌬gfp B cells were unresponsive. Therefore, CR binding of C3d tetramers and signaling via CD19 are functionally uncoupled in the Cr2 ⌬/⌬gfp B cells, leading to an impaired proliferation in vitro.
In Vivo Transport of ICs. Previous studies have reported that naive B cells bind ICs through the CR and transport them into the B-cell follicle (25, 26) . To determine whether transport of ICs into the follicle is dependent on coupling of CR to CD19, WT, Cr2 Ϫ/Ϫ , and Cr2 ⌬/⌬gfp mice were passively immunized with anti-B-phycoerythrin (PE) antibody and 24 h later were injected s.c. in the hind flanks with 10 g of B-PE. The draining inguinal LNs were collected 8 h later and analyzed by FACS. As expected, Cr2
Ϫ/Ϫ B cells bound negligible PE-ICs. By contrast, both WT and mutant B cells bound appreciable levels of PE-ICs ( Fig. 2 A and B) . Thus, Cr2
⌬/⌬gfp B cells, although uncoupled from CD19, retain the ability to transport PE-ICs into the follicle.
To compare the retention of PE-ICs on FDCs in mice with intact CR/CD19 versus the mutant Cr2 ⌬/⌬gfp receptor, the inguinal LNs of the passively immunized mice were collected 24 h after PE injection. Confocal microscopic analysis identified a similar level of PE-ICs colocalized with FDCs in both WT and Cr2 ⌬/⌬gfp mice ( To examine further the uptake of ICs in real time by FDCs in Cr2
⌬/⌬gfp mice, we took advantage of the endogenous expression of GFP. Note that GFP levels were not sufficiently intense for imaging in vivo of the mutant follicular B cells, whereas the levels were Ϸ10-fold higher on FDCs. Cr2 ⌬/⌬gfp mice were injected in the footpad with 1 g of preformed ICs comprising Alexa 633-labeled turkey egg lysozyme (TEL) and rabbit anti-lysozyme. In a previous report, we found that labeled TEL alone injected in the footpad rapidly filled the SCS of the popliteal LNs and drained into the follicles via discrete conduits (26) . In the current study, TEL-IgG complexes were used to activate C3 and enhance uptake on FDCs via CD21/CD35 receptors. Subsequently, the draining popliteal LNs were surgically exposed and imaged by multiphoton intravital microscopy. TEL Ag (red) colocalized with the FDC dendritic processes (green) ( Fig. 2D ; see also Movie S1). Follicular conduits (identified by second harmonic signals; blue), which were shown recently to channel small Ags from the SCS into the FDC area, colocalized with the FDCs (26) . Thus, the mutant line of mice could be used in future studies to track uptake of labeled Ag onto FDC by intravital microscopy and to address whether uptake via CD21/ CD35 receptors induces signaling.
Humoral Immunity in CR Mutant Mice. To examine the intrinsic effect of uncoupling of CR and CD19 on B cells in vivo, a bone marrow (BM) transplantation approach was used. The chimeric mice bore CR ϩ FDCs from the WT C57BL/6 recipients, but the B-cell compartment was derived from WT, Cr2 Ϫ/Ϫ , or Cr2 ⌬/⌬gfp donor BM. BM chimeric mice were immunized with either a high or low dose of 4-hydroxy-3-nitrophenyl conjugated to keyhole limpet hemocyanin (NP-KLH) at 0 and 3 weeks, and antibody responses were analyzed (Fig. S2) . A potential disadvantage of the chimeric approach is increased variation among individual mice. However, the overall advantage is that the FDCs are consistently Cr2 ϩ/ϩ . In response to high-dose Ag (50 g i.v.), both WT and Cr2 ⌬/⌬gfp mice responded comparably (Fig. 3A Right) . Further, the frequency of NP-specific antibody-secreting cells (B ASC s) was similar in the BM of both WT and Cr2 ⌬/⌬gfp (Fig. 3B Right) . Although the numbers of B ASC s in the spleens of Cr2 ⌬/⌬gfp mice were dramatically higher than Cr2 Ϫ/Ϫ , they were only about one-half that of WT. As expected, Cr2
Ϫ/Ϫ mice failed to generate significant serum antibody titer to the hapten NP, and they also showed a markedly reduced frequency of NP-specific B ASC s (Fig. 3) . Therefore, humoral responses to high-dose soluble Ag were comparable between WT and Cr2 ⌬/⌬gfp B cells. Complement-dependent antibody responses are most apparent with lower amounts of Ag. Thus, humoral responses were measured 10 days after challenge with a low dose of Ag (10 g i.v.). WT chimeras yielded a significantly greater titer than Cr2 Ϫ/Ϫ chimeras (Fig. 3A Left) . Importantly, the IgG anti-NP titers were also reduced in Cr2
⌬/⌬gfp relative to WT chimeras (Fig. 3A) . Further, after 7 weeks, the decay in circulating NP-specific antibody was greater in the Cr2 Ϫ/Ϫ and mutant mice than Cr2 ϩ chimeras. Although it correlated directly with serum anti-NP IgG titers, the frequency of B ASC s was markedly higher in immunized Cr2 ϩ chimeras compared with Cr2
Ϫ/Ϫ and Cr2 ⌬/⌬gfp cohorts (Fig. 3B Left) . Thus, uncoupling of CR and CD19 substantially reduced humoral immunity relative to WT, but mutant CRs contributed to an enhanced response relative to Cr2 Ϫ/Ϫ .
GC Responses in CR Mutant
Mice. Given the reduced secondary response to low-dose Ag observed in the Cr2 Ϫ/Ϫ and Cr2 ⌬/⌬gfp mice, GC B cells were compared among the three groups of immunized mice. Ten days after secondary immunization with low-dose NP-KLH, the numbers of peanut agglutinin (PNA) high B220 ϩ B cells were quantitated. WT, Cr2
Ϫ/Ϫ , and Cr2 ⌬/⌬gfp BM chimeric mice did not differ statistically (Fig. S3 and Table 1 ). By contrast, a significant reduction was observed in the number of Cr2 Ϫ/Ϫ NP ϩ B cells relative to WT that had undergone class switch recombination (CSR) (IgM Ϫ ) (Table 1) . Similarly, the number of PNA high NP ϩ IgM Ϫ B cells prepared from Cr2 ⌬/⌬gfp mice was reduced relative to WT (Fig. 4 A and B, and Table 1 ). Thus, efficient CSR of the NP ϩ B cells required an intact CR CD19 coreceptor. This could be explained by a requirement for coreceptor signaling for efficient Ag presentation to cognate T cells (38) and/or for enhanced up-regulation of survival genes, such as Bcl-2, cFLIP, or Bcl-xl (39, 40 (Table 1) . However, when the NP ϩ IgM ϩ population was examined for surface IgD levels, the highest mean fluorescence 
intensity (MFI) for IgD was consistently NP
ϩ IgM ϩ Cr2 Ϫ/Ϫ and Cr2 ⌬/⌬gfp B cells (Fig. 4C) .
B-Cell Memory in Mutant
Mice. GCs serve to produce long-term protective humoral immunity via production of Ag-specific memory cells (B MEM s) and B ASC s (42, 43) . To determine whether B-cell memory correlates with the block in isotype switch observed in PNA high cells, two approaches were taken using splenic B cells from immunized BM chimeric mice: (i) cells were analyzed by FACS 7 weeks after challenge with low-dose soluble Ag, and the number of NP-binding B cells was quantitated, and (ii) B cells were adoptively transferred along with T cells from KLH-primed mice into Rag-1 Ϫ/Ϫ mice, and recipients were subsequently challenged with 50 g of Ag in adjuvant, and antibody titers were determined (Fig. S4) .
GC responses began to dissipate by 3 weeks after Ag encounter. To evaluate the production of B MEM cells, BM chimeric mice were analyzed by FACS 7 weeks after immunization with low-dose Ag. As predicted, the number of NP-binding B cells was reduced over the time period analyzed for all three strains (Table 1 As an additional measure of B-cell memory, a Rag-1 Ϫ/Ϫ chimeric mouse model was used (Fig. S4) . Rag-1 Ϫ/Ϫ mice were reconstituted with a mixture of hapten-primed splenic B cells and carrier-primed T cells. Rag-1 Ϫ/Ϫ chimeras receiving B cells from immunized WT mice had a mean IgG anti-NP titer significantly greater than recipients of Cr2 Ϫ/Ϫ B cells (Fig. 5B) (Fig. 5C) . Thus, coreceptor signaling is a critical factor in formation and maintenance of long-term B MEM , but CRs appear to play additional role/roles in memory that are independent of CD19.
Discussion
In the current study, we introduced a mutation within the murine Cr2 locus to uncouple the functional interaction between complement receptors CD21 and CD35 (CRs) from CD19 based on earlier studies in a human B-cell line (32) . The mutant receptor, Cr2 ⌬/⌬gfp , binds C3 ligands and includes the CD35 domain that has complement regulatory activity (Nterminal domain) but impaired coreceptor signaling. To evaluate the intrinsic effect on B cells, a BM chimeric approach was These results are consistent with the interpretation of findings from earlier studies in Cr2 Ϫ/Ϫ mice and Cr2 Ϫ/Ϫ BM chimeric mice that coreceptor signaling is critical for efficient humoral immunity to T-dependent Ags (15, 16, 44) . Importantly, the new results identify the stage in GC differentiation in which coreceptor signaling is required (i.e., IgM ϩ IgD ϩ to IgM ϩ IgD Ϫ ). Wang and Carter (45) identified a block in differentiation at a similar stage in GC B cells in CD19 Ϫ/Ϫ and CD19 Ϫ/Ϫ transgenic mice that express mutant CD19 (Y482F/Y513F). In their study, analysis of GC by BrdU labeling and histology identified arrest in differentiation of mutant B cells in the FDC light zone. This region of the GC is thought to promote clonal selection of B cells and includes cognate T cells as well as C3d-coated Ag.
One explanation for the signaling requirement of coreceptor within the GC light zone could be efficient presentation of Ag to Efficient class switch recombination and generation of B-cell memory are dependent on intact CR-CD19 coreceptors. GC B cells were enumerated in chimeric mice containing WT-derived FDCs and either WT, Cr2 Ϫ/Ϫ , or Cr2 ⌬/⌬gfp BM-derived B cells after immunization with 10 g (low dose) of NP-KLH. Total numbers of GC B cells (second column), NP-specific B cells expressing surface IgM (third column), or NP-specific B cells that had undergone class switch recombination (fourth column) were assessed at 10 days after immunization by multiplying their frequency, as determined by flow cytometry, by the total splenocyte count. At 7 weeks after immunization, NP-specific memory B cells (B MEMs) were quantitated in WT vs. Cr2 Ϫ/Ϫ and Cr2 ⌬/⌬gfp chimeras (fifth column).
cognate T cells to ensure costimulation and up-regulation of activation-induced cytidine deaminase. Pierce and colleagues (46) reported that coupling of C3d to HEL enhanced localization of BCR and coreceptor (CD19/CD21/CD81) in lipid rafts, resulting in prolonged signaling and presentation of Ag to T cells. The tetraspan protein CD81 interacts with CD19 and facilitates localization of the coreceptor and BCR in lipid rafts, and this enhances signaling via Ig ␣ and vav (47) . CD81-deficient mice have reduced responses to certain T-dependent Ags and increased responses to type II T-independent Ags (48) . Moreover, the deficient mice have reduced numbers of B-1 cells, probably resulting from impaired expression of CD19 (49) . Similarly, CD19 Ϫ/Ϫ mice have a block in GC response to T-dependent Ags, as discussed above, and a deficiency in B-1 cells (50) .
This stage of differentiation is also critical for up-regulation of survival factors, such as Bcl-2 and Bcl-xl, and overexpression of these survival genes leads to excess survival of low-affinity GC B cells (39, 40) . Thus, cross-linking of coreceptor enhances upregulation of Bcl-2 (51) and Bcl-xl (52) and would enhance continued B-cell differentiation within the GC.
Not all T-dependent Ags require CR for development of humoral immunity, because the nature of the Ag and dose are important factors. For example, Cr2
Ϫ/Ϫ mice appear to respond to infectious vesicular stomatitis virus similarly to WT controls (14) . Similarly, Cr2
Ϫ/Ϫ mice immunized with bacteriophage (QB phage) developed an apparently normal GC response, with a frequency of B memory cells and early antibody titers similar to those of WT controls; however, the antibody response failed to persist, as had been observed in responses to haptenated proteins (53) . Interestingly, it was found that transcription factors Blimp-1 and XBP-1 were not efficiently up-regulated by post-GC plasma cells in the Cr2 Ϫ/Ϫ mice and that the defect was intrinsic to the B cells. Although the current study did not evaluate expression of Blimp-1 and XBP-1, identification of a general block in B-cell differentiation within the GC would explain the actual reduction in the number of Ag-specific B ASC s and B MEM s.
Although the humoral response of Cr2 ⌬/⌬gfp mice was impaired relative to WT mice, it was less severe than that of Cr2 Ϫ/Ϫ mice. This finding might be explained by a low level of functional interaction between mutant CR and CD19. Although we cannot rule out this possibility, negligible coreceptor activity was observed by using two sensitive assays in vitro. Moreover, the observation of a similar increase in expression of CD19 on B-cell surfaces in both the Cr2 ⌬/⌬gfp and Cr2 Ϫ/Ϫ mice supports a physical separation between CD19 and the mutant receptor. By contrast, functional activity involving binding of C3d or transport of C3d-coupled ICs appeared normal in the mutant mice.
The less severe defect in Cr2 ⌬/⌬gfp relative to Cr2 Ϫ/Ϫ mice supports CD19-independent role/roles of CR. For example, mutant B cells retain the ability to bind and transport C3d-coated ICs into the B-cell follicles. Recent studies highlight the importance of B-cell transport of Ag in both the spleen and peripheral LNs (23, 25, 26) . In addition, Shlomchik and Rossbacher demonstrated that binding of Ag by cognate B cells in Ig-deficient mice could activate C3 on the cell surface, resulting in coupling of C3b to the specific Ag (54) . Moreover, focusing of Ag-C3d complexes on the surface of cognate B cells could enhance ''presentation'' to neighboring B cells or transport to FDCs (55) . Thus, the responsiveness and differentiation of B cells in mutants relative to Cr2 Ϫ/Ϫ could be explained in part by increased efficiency of cognate B cells in presentation of C3d-coated Ags to neighboring B cells (or deposition on FDC).
Finally, although a requirement for complement regulatory activity by CD35 on B cells has not been reported, it is possible that the less impaired response of mutant B cells could be explained in part by the expression of CR. Thus, complete absence of CR on Ag-binding B cells might increase their sensitivity to complement injury. By contrast, B cells in WT and mutant mice retain full CRP activity.
In summary, characterization of a novel line of mutant mice in which CRs are uncoupled from CD19 on B cells confirms the importance of coreceptor signaling for efficient response to Tdependent Ags. However, the finding of a less impaired humoral Statistical analyses are indicated: * , P Յ 0.035; ** , P Յ 0.05. Total splenic B cells isolated 7 weeks after boost were adoptively transferred into Rag1 Ϫ/Ϫ recipients along with carrier-primed T cells from WT mice. After 2 weeks, Rag1 Ϫ/Ϫ chimeras were immunized with 50 g of NP5-KLH in alum, and IgG anti-NP titers (B) and ASCs (C) were measured as described. Shown is a summary from two experiments; statistical significance is indicated ( * , P Յ 0.03; ** , P Յ 0.04).
response relative to Cr2 Ϫ/Ϫ mice suggests a role for CRs independent of CD19.
Materials and Methods
Antibody Titer. Serum was collected from individual mice, and NP-specific antibody titers were determined by sandwich ELISA, as described previously (56) .
C3d
Tetramers. Functional binding of C3d on B cells was confirmed by using the approach of Henson et al. (57) . C3d was kindly provided by David Karp (University of Texas Southwestern School of Medicine, Dallas, TX). Mixed tetramers of F(ab) 2Ј goat anti-mouse IgM and C3d were prepared as described and were purified by gel filtration (37) .
Chimeric Rag1 ؊/؊ Mice. The generation of chimeric Rag1 Ϫ/Ϫ mice is described in SI Text.
Flow Cytometric Analysis. Antibodies and reagents used for flow cytometry are described in SI Text.
Histology. Histological analyses are described in SI Text.
Immunogens and Immunizations. NP-KLH was used at two doses for i.v. immunizations: 10 g (low dose) or 50 g (high dose). Mice were analyzed 2 to 3 weeks after primary immunization and 1 to 6 weeks after boost. The formation of ICs in vivo and analysis of IC uptake was described previously (26) .
Mice and BM Chimeras. Mice were housed at the Immune Disease Institute (IDI) and Harvard Medical School (HMS) in specific pathogen-free facilities. MD4 HEL Ig Tg mice were maintained on a C57BL/6 background, with either WT (36), Cr2-deficient (Cr2 Ϫ/Ϫ ) (17), or mutant (Cr2 ⌬/⌬gfp ) Cr2 locus. A BM chimera approach was used to localize CR mutation to the B-cell population, as described previously (16) . All animal procedures were Institutional Animal Care and Use Committee-approved at IDI and HMS.
